Zitate

APA-Zitierstil (7. Ausg.)
Ma, G., You, S., Xie, Y., Gu, B., Liu, C., Hu, X., . . . Yang, Z. (2023). Pretreatment 18F‐FDG uptake heterogeneity may predict treatment outcome of combined Trastuzumab and Pertuzumab therapy in patients with metastatic HER2 positive breast cancer. BMC.
Chicago-Zitierstil (17. Ausg.)
Ma, Guang, Shuhui You, Yizhao Xie, Bingxin Gu, Cheng Liu, Xichun Hu, Shaoli Song, Biyun wang, und Zhongyi Yang. Pretreatment 18F‐FDG Uptake Heterogeneity May Predict Treatment Outcome of Combined Trastuzumab and Pertuzumab Therapy in Patients with Metastatic HER2 Positive Breast Cancer. BMC, 2023.
MLA-Zitierstil (9. Ausg.)
Ma, Guang, et al. Pretreatment 18F‐FDG Uptake Heterogeneity May Predict Treatment Outcome of Combined Trastuzumab and Pertuzumab Therapy in Patients with Metastatic HER2 Positive Breast Cancer. BMC, 2023.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.